ClinByte

Session 8.2 - Aggregate Reporting - IND and NDA in Argus Safety

This session will cover the workflow of Aggregate Reporting - Investigational New Drug Application (IND) and New Drug Application (NDA) in the Oracle Argus Safety application.

This session is a part of the Oracle Argus Safety Essentials program at https://www.clinbyte.com

The programs includes Tutorials, Recorded lectures, Quizzes and practical assignments for a holistic learning experience on managing pharmacovigilance data using Oracle Argus Safety.

The following topics are covered as part of this program:

1. Overview of Pharmacovigilance
2. Oracle Argus Safety - Navigation
3. Overview of Argus Menus & Business Process Workflow
4. Case Form Features
5. Case Processing
6. Drug and Event Coding
7. Advanced Conditions
8. Reporting and Submissions
9. Course Completion

Enrol for the program at https://lms.clinbyte.com

Session 8.2 - Aggregate Reporting - IND and NDA in Argus Safety This session will cover the workflow of Aggregate Reporting - Investigational New Drug Application (IND) and New Drug Application (NDA) in the Oracle Argus S...